Tag: Takeda
Alkem Laboratories signs licensing agreement with Takeda to launch Vonoprazan in...
Vonoprazan, a novel treatment for GERD and other gastric conditions, will be marketed by Alkem Laboratories under the brand name "Vonzai"
USAID and Takeda launch Dengue prevention campaign
“हारेगा डेंगू, हराएंगे हम” campaign launched to spread awareness regarding dengue prevention and control
G20 Summit 2023: Takeda emphasizes diversity, equity & inclusion as essential...
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
Takeda spearheads initiatives to strengthen health system for rare diseases in...
These initiatives aim to improve access to healthcare for rare disease patients
Takeda pledges support to HAE patients through its ‘Sunrise patient support...
The initiative aims to drive HAE awareness through patient education, and timely diagnosis through free of cost diagnostics as the key growth drivers to address priority unmet needs
Takeda showcases digital health solutions at G20 Meeting in India
The company showcased digital innovations - MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
Takeda India recognized as top employer for third consecutive year
The company is among 15 companies worldwide to receive global certification for the year 2023
Four pharma giants join hands to reduce environmental burden in pharma...
Astellas, Eisai, Daiichi Sankyo, and Takeda aim to ensure that society benefits from this collaboration to harmonize corporate activities with the global environment
Takeda’s tetravalent vaccine for Dengue approved for use in European Union
Effective dengue prevention requires a multi-faceted approach, and previous methods have been insufficient for a number of reasons
Takeda becomes a signatory of UNGC in India
Over the years, with its journey in India, Takeda has been a key industry leader in establishing ethical practices as a global corporate